Shares more than doubled in value after Phase 3 results suggested Alumis’ pill may compare favorably with other emerging oral ...

Shares of Alumis ALMS surged 95.3% on Jan. 6, after the company announced positive top-line data from its two phase III ...

Psoriasis is a skin condition involving scaly plaques that can cause itching and pain. Many treatments are available. Switching psoriasis medications should be an informed decision with overall ...

Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...

In an ideal world, there would be one magical medication to effectively treat psoriasis for each person with the condition. But anyone with an autoimmune disease, including psoriasis, can have varying ...

Posters presented at the American Academy of Dermatology Annual Meeting identified significant undertreatment of psoriasis and significant gaps in biologic medication treatment. This content was ...